Pfizer has your back

in the fight against cancer

With over 50+ programs, 80+ clinical trials worldwide and 40% of our R&D budget dedicated to oncology, we're committed to advancements in cancer care

The fight against cancer continues with “One More”

In the fight against cancer, “one more” matters - one more wedding, one more hug, one more trial. Healthcare professionals won’t stop fighting for their patients, and neither will we.

Learn More at Let’sOutdoCancer.com


We're Not Waiting for Breakthroughs - We're Working to Create Them

A cancer breakthrough isn’t one moment. It’s decades of research, millions of data points, and resilience in the face of setbacks – all with the hope of challenging what’s possible.
We’re not waiting for breakthroughs – we’re working to create them.

Learn More in USA Today


Advancing Cancer Care with Cutting-Edge Science

Powered by science and advanced technologies, we are committed to rapidly advancing novel combinations and next- generation biologics across a wide range of cancers – so that people with cancer can live better and longer lives.

Explore Pfizer Oncology

Latest Articles

Programs & Initiatives

Pfizer's Global Health Fellows Program: Leveraging Colleagues’ Expertise to Help Improve Healthcare Access Around the World

Global Health Fellows (GHF) is Pfizer’s signature skills-based volunteering program, empowering colleagues to lend their skills and expertise.

Purpose & Ideals

The Mindfulness of Medicine Development: How Scientists Are Driving the Next Wave of Medical Innovations

For millions of patients around the world, the development of a new treatment or vaccine can be life-changing.

Programs & Initiatives

Bridging Global Gaps in Hemophilia Care

Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies.

More Articles

Products

Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.

Pfizer RxPathways

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings.

Explore RxPathways

About

Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure.

Learn More About Us

Pipeline Snapshot as of August 5, 2025

46

Phase 1

30

Phase 2

28

Phase 3

4

Registration

108

Total

Explore the Product Pipeline Download Complete Pipeline PDF

Areas of Focus

Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases.

Internal Medicine

Inflammation & Immunology

Vaccines

An Accord for a Healthier World

Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes.

Learn More About The Accord

Coronavirus Resources

Our scientific efforts played an important role during a global health crisis. Learn more about SARS-CoV-2, the coronavirus that causes COVID-19 disease, and Pfizer’s work throughout the pandemic.

More On COVID-19
Vaccines
Severe COVID & High Risk Populations

What is severe COVID-19? Learn about severe COVID-19 and its symptoms and risk factors Resources and answers to frequently asked questions.

Learn About Severe COVID
Vaccines
Recursos para Hispanohablantes (Resources for Spanish-Speakers)

El Dr. Santiago López informa en temas relacionados a la atención médica tales como vacunas, noticias falsas, y ensayos clínicos.

Aprende más

Sign Up for communications from Pfizer

Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.

Sign up now